Parry D M, Pedersen P L
J Biol Chem. 1983 Sep 25;258(18):10904-12.
A detailed investigation concerned with localizing hexokinase in the Novikoff ascites tumor is presented. At least 50% of the total hexokinase activity was shown by differential and density gradient centrifugation techniques to be associated with tumor mitochondria. None of this activity was latent. Fractionation of isolated tumor mitochondria with digitonin revealed an outer membrane location for this enzyme. Treatment of tumor mitochondria with glucose 6-phosphate released about 80 to 85% of the hexokinase activity without disrupting the intermembrane compartment. This suggests that at least this proportion of the activity is bound to the outer surface of the outer membrane. Successive treatments did not remove the remaining hexokinase activity. At 30 degrees C, an incubation time of about 10 min with glucose 6-phosphate was required to achieve maximal release. No solubilization occurred at 0-4 degrees C. The isozymes derived from Novikoff mitochondria were identified by anion exchange chromatography as types I and III. Glucokinase activity was not detectable. Evidence is also presented which indicates that the hexokinase obtained from Novikoff mitochondria binds to the outer membrane of rat liver mitochondria. In contrast, the low endogenous hexokinase activity present in isolated liver mitochondria was found not to fractionate with outer membrane markers, but rather with contaminating microsomal membrane markers. Results described here provide the first direct evidence for the submitochondrial location of hexokinase in a tumor. They reveal an outer membrane location and an involvement of two hexokinase isozymes. Because these findings are characteristic of the hepatoma and not observed in control liver preparations, it is suggested that they may be very relevant to the general property of rapidly growing tumors to catabolize large amounts of glucose.
本文介绍了一项关于诺维科夫腹水瘤中己糖激酶定位的详细研究。通过差速离心和密度梯度离心技术显示,至少50%的总己糖激酶活性与肿瘤线粒体相关。该活性均无潜伏性。用洋地黄皂苷对分离的肿瘤线粒体进行分级分离,发现该酶位于外膜。用6-磷酸葡萄糖处理肿瘤线粒体可释放约80%至85%的己糖激酶活性,且不会破坏膜间区。这表明至少这部分活性与外膜外表面结合。连续处理并未去除剩余的己糖激酶活性。在30℃下,需要用6-磷酸葡萄糖孵育约10分钟才能实现最大释放。在0-4℃下没有发生溶解。通过阴离子交换色谱法鉴定,来自诺维科夫线粒体的同工酶为I型和III型。未检测到葡萄糖激酶活性。还提供了证据表明,从诺维科夫线粒体获得的己糖激酶与大鼠肝线粒体的外膜结合。相比之下,发现分离的肝线粒体中存在的低内源性己糖激酶活性与外膜标记物无关,而是与污染的微粒体膜标记物有关。此处描述的结果为肿瘤中己糖激酶的亚线粒体定位提供了首个直接证据。它们揭示了外膜定位以及两种己糖激酶同工酶的参与。由于这些发现是肝癌的特征,而在对照肝脏制剂中未观察到,因此表明它们可能与快速生长的肿瘤分解大量葡萄糖的一般特性非常相关。